| |
| |
|
| Insider
Information: |
Ingram Robert Alexander |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
516,452 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,141,116 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
516,452 |
|
|
| Total
Value |
$6,141,116 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -59.5%
|
 33.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
Director |
2015-05-15 |
32,367 |
2004-05-13 |
0 |
Premium* |
|
|
Lowes Companies Inc |
LOW |
Director |
2010-05-27 |
0 |
2005-05-27 |
0 |
Premium* |
|
|
Wolfspeed |
WOLF |
Director |
2018-10-17 |
77,710 |
2008-12-29 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-03-31 |
92,046 |
2010-09-28 |
0 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-05-18 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2015-05-27 |
1,500 |
2015-05-22 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-02-28 |
100,198 |
2016-09-01 |
0 |
Premium* |
|
|
Novan, Inc. |
NOVN |
Director |
2019-05-22 |
169,777 |
|
0 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2022-12-16 |
42,854 |
2020-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NOVN |
Novan, Inc. |
Director |
– • – |
2016-09-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,000 |
|
- |
|
| LOW |
Lowes Companies Inc |
Director |
– • – |
2008-05-21 |
4 |
OE |
$17.96 |
$143,640 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2010-02-18 |
4 |
OE |
$30.40 |
$363,973 |
D/D |
11,866 |
40,331 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2010-02-18 |
4 |
OE |
$89.90 |
$1,066,753 |
D/D |
11,866 |
28,465 |
0 |
- |
|
| LOW |
Lowes Companies Inc |
Director |
– • – |
2010-05-27 |
4 |
OE |
$21.13 |
$169,040 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2010-11-16 |
4 |
OE |
$17.43 |
$79,981 |
D/D |
4,590 |
65,892 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-05-22 |
4 |
OE |
$293.53 |
$1,956,965 |
D/D |
6,667 |
6,667 |
0 |
- |
|
| WOLF |
Wolfspeed |
Director |
– • – |
2015-12-01 |
4 |
OE |
$14.71 |
$55,163 |
D/D |
3,750 |
52,596 |
0 |
- |
|
| WOLF |
Wolfspeed |
Director |
– • – |
2018-08-30 |
4 |
OE |
$30.92 |
$123,680 |
D/D |
4,000 |
76,950 |
0 |
- |
|
| LOW |
Lowes Companies Inc |
Director |
– • – |
2008-05-21 |
4 |
S |
$23.92 |
$191,485 |
D/D |
(8,000) |
0 |
0 |
- |
|
| LOW |
Lowes Companies Inc |
Director |
– • – |
2010-05-27 |
4 |
S |
$24.68 |
$197,404 |
D/D |
(8,000) |
0 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2010-11-16 |
4 |
S |
$65.00 |
$298,350 |
D/D |
(4,590) |
61,302 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2010-11-30 |
4 |
S |
$66.33 |
$331,650 |
D/D |
(5,000) |
56,302 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2011-02-28 |
4 |
S |
$40.00 |
$394,880 |
D/D |
(9,872) |
0 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2011-02-28 |
4/A |
S |
$40.00 |
$394,880 |
D/D |
(9,872) |
217,724 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2011-05-09 |
4 |
S |
$87.79 |
$877,900 |
D/D |
(10,000) |
46,302 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
– • – |
2012-05-25 |
4 |
S |
$87.72 |
$1,315,800 |
D/D |
(15,000) |
36,856 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2014-07-31 |
4 |
S |
$90.26 |
$1,128,279 |
D/D |
(12,500) |
30,541 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-05-27 |
4 |
S |
$513.39 |
$707,965 |
D/D |
(1,379) |
1,500 |
0 |
- |
|
| WOLF |
Wolfspeed |
Director |
– • – |
2015-12-01 |
4 |
S |
$27.67 |
$103,755 |
D/D |
(3,750) |
48,846 |
0 |
- |
|
145 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
